APPLICATIONS PUBLISHED 31 JULY 2002

Published: 1-Jan-2003

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Compsn and method of cancer antigen immunotherapy
    Wood, Gary 1225870*

  • Method and formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained
    Seed Capital Investment 1225871*

  • New and improved formulation for paclitaxel
    SuperGen 1225872*

  • Amphiphilic polymeric vesicles
    BioCure 1225873*

  • Apparatus and process for preparing crystalline particles
    Glaxo Group 1225875*

  • Gastroresistant tablets for alimentary, dietetic and therapeutic use
    Truffini & Regge' Farmaceutici Srl 1225876*

  • Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
    Neurotherapeutics 1225877*

  • Treatment of emphysema using RAR selective retinoid agonists
    F Hoffmann-La Roche 1225878*

  • Ophthalmic formulation of dopamine antagonists
    Orbon Corp 1225879*

  • Use of a HMG-CoA reductase inhibitor for treating amyloid beta precursor disorders
    Andrx Corp 1225880*

  • Methods of using rapid-onset selective serotonin reputake inhibitors for treating sexual dysfunction
    Eli Lilly 1225881*

  • Selective COX-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
    Vanderbilt University 1225882*

  • Anti-ischaemic compounds
    Societe de Conseils de Recheches et d'Applications Scientifiques 1225883*

  • Method for administering a phosphodiesterase 4 inhibitor
    SmithKline Beecham Corp; SmithKline Beecham plc 1225884*

  • A therapeutic mixture of HMG-CoA reductase inhibitors
    Nitrosystems 1225885*

  • Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
    Warner-Lambert; Yamanouchi Pharmaceutical 1225886*

  • Antimicrobial compsns comprising polyglutamic acid and optionally metal salts
    Procter & Gamble 1225887*

  • Sustained-release formulations for treating CNS-mediated disorders
    NPS Pharmaceuticals 1225888*

  • Medicament combinations of nifedipine and cerivastatin
    Bayer 1225889*

  • Rivastigmine for the treatment of ocular disorders
    Novartis 1225890*
  • You may also like